We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGS
651
DELISTED
PlayAGS
AGS
-80,155
Closed -$971K
AIZ icon
652
Assurant
AIZ
$13.7B
-4,575
Closed -$960K
ALB icon
653
Albemarle
ALB
$13.7B
-7,579
Closed -$546K
APLS
654
DELISTED
Apellis Pharmaceuticals
APLS
-159,054
Closed -$3.48M
AUTL
655
Autolus Therapeutics
AUTL
$389M
-3,191,401
Closed -$4.95M
BBAR icon
656
BBVA Argentina
BBAR
$3.92B
-67,000
Closed -$1.21M
BEN icon
657
Franklin Resources
BEN
$17.3B
-46,335
Closed -$892K
BIO icon
658
Bio-Rad Laboratories Class A
BIO
$8.47B
-13,504
Closed -$3.29M
BMA icon
659
Banco Macro
BMA
$5.89B
-233,000
Closed -$17.6M
BZ icon
660
Kanzhun
BZ
$7.03B
-348,434
Closed -$11M
CNO icon
661
CNO Financial Group
CNO
$4.96B
-109,559
Closed -$4.56M
VISN
662
Vistance Networks Inc
VISN
$2.67B
-15,685
Closed -$83.3K
CYTK icon
663
Cytokinetics
CYTK
$10.9B
-145,191
Closed -$5.84M
DFS
664
DELISTED
Discover Financial Services
DFS
-85,995
Closed -$14.7M
DKS icon
665
Dick's Sporting Goods
DKS
$18.4B
-1,239
Closed -$250K
DLB icon
666
Dolby
DLB
$4.85B
-28,664
Closed -$2.3M
ENPH icon
667
Enphase Energy
ENPH
$5.01B
-87,910
Closed -$5.45M
ENS icon
668
EnerSys
ENS
$6.94B
-18,422
Closed -$1.69M
GPCR icon
669
Structure Therapeutics
GPCR
$3.46B
-214,063
Closed -$3.71M
HAS icon
670
Hasbro
HAS
$12.8B
-7,838
Closed -$482K
HDB icon
671
HDFC Bank
HDB
$119B
-16,960
Closed -$563K
HST icon
672
Host Hotels & Resorts
HST
$17.1B
-50,701
Closed -$720K
ILMN icon
673
Illumina
ILMN
$28.7B
-82,131
Closed -$6.52M
IPG
674
DELISTED
Interpublic Group of Companies
IPG
-10,552
Closed -$287K
KURA icon
675
Kura Oncology
KURA
$901M
-422,652
Closed -$2.79M

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.